THURSDAY, July 13, 2017 -- Typically, better-paying jobs and those that require higher education are thought more desirable, but a new study suggests white collar workers have a higher risk of death from two neurodegenerative diseases.
The research found that richer, better-educated people with Parkinson's disease or amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), appear more likely to die from these diseases than those in lower paying or less educationally demanding work.
FRIDAY, Aug. 4, 2017 -- The diabetes drug exenatide (Byetta) may do double duty as a treatment for Parkinson's disease, a new study suggests.
"This is a very promising finding, as the drug holds potential to affect the course of the disease itself, and not merely the symptoms," said senior study author Tom Foltynie, from University College London's Institute of Neurology.
FRIDAY, July 7, 2017 -- People with Parkinson's disease are about four times more likely to develop melanoma skin cancer, and conversely, people with melanoma have a fourfold higher risk of getting Parkinson's, researchers report.
Although doctors have known about the connection between these diseases, they still don't know why having one increases the risk of the other.
TUESDAY, July 11, 2017 -- Changes in vision may be an early sign of Parkinson's disease, researchers report.
The neurodegenerative condition is caused by the loss of neurons in several brain structures, resulting in tremors, rigidity or stiffness, along with impaired balance and coordination, the Italian researchers explained.